Skip to main content

Web Exclusives

Practice Management
Survey Shows Inflation Affecting Majority of Consumer Healthcare Decisions
Read More
Original Research, Practice Management
Clinical and Financial Impacts of an Ambulatory Oncology Pharmacist–Based Intravenous Chemotherapy Education and Follow-Up Program
Grant W. Lee, PharmD, BCOP; Joseen J. Chundamala, PharmD; Kerri L. Monahan, PharmD; Judy J. Cho, PharmD; Lydia J. Berry, RPh, PharmD; Christine G. Cambareri, PharmD, BCOP, CSP
Read More
FDA Approvals
Talzenna Received a New Indication, With Enzalutamide, for Metastatic Castration-Resistant Prostate Cancer With HRR Gene Mutation
Read More
FDA Approvals
Nubeqa Now Indicated for Metastatic Hormone-Sensitive Prostate Cancer
Read More
FDA Approvals
Imfinzi Receives New FDA Indication for Advanced or Metastatic Biliary Tract Cancer
Read More
FDA Approvals
Retevmo Receives New FDA Indication for Advanced Solid Tumors with RET Fusion
Read More
FDA Approvals
Pemazyre Receives New Indication for FGFR1-­Positive Myeloid/Lymphoid Neoplasms
Read More
FDA Approvals
Imbruvica Now Also Indicated for Children with Chronic Graft-versus-Host Disease
Read More
FDA Approvals
Enhertu First FDA-Approved Treatment for HER2-Low Breast Cancer
Read More
FDA Approvals
Vegzelma a New Biosimilar FDA Approved for the Treatment of 6 Types of Cancer
Read More
Page 7 of 37
Results 61 - 70 of 362